Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2012
05/17/2012US20120122893 Methods of treating cancer
05/17/2012US20120122892 Chemical compounds
05/17/2012US20120122891 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
05/17/2012US20120122890 Potassium Channel Modulators
05/17/2012US20120122889 Small molecule inhibitors of necroptosis
05/17/2012US20120122888 Potassium Channel Modulators
05/17/2012US20120122887 Solid state forms of a potent hcv inhibitor
05/17/2012US20120122886 Thiadiazole-substituted arylamides as p2x3 and p2x2/3 antagonists
05/17/2012US20120122885 Pyruvate kinase m2 modulators, therapeutic compositions and related methods of use
05/17/2012US20120122884 Compounds useful as inhibitors of atr kinase
05/17/2012US20120122883 New salts
05/17/2012US20120122882 Substituted Pyrrolo-Pyrimidine Derivatives, Process for Their Preparation and Their Use as Kinase Inhibitors
05/17/2012US20120122881 Formulation of quinazoline based egfr inhibitors containing a zinc binding moiety
05/17/2012US20120122880 Thioxanthene derivatives for the treatment of infectious diseases
05/17/2012US20120122879 Compounds useful as protein kinase inhibitors
05/17/2012US20120122878 Combination products
05/17/2012US20120122877 Compositions for Treating Bacterial Infections
05/17/2012US20120122876 Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
05/17/2012US20120122875 Salts of Methyl (R)-7-[3-Amino-4-(2,4,5-Trifluoro-Phenyl)-Butyryl]-3-Trifluoromethyl-5,6,7,8-Tetrahydro-Imidazo[1,5-A]Pyrazine-1-Carboxylate
05/17/2012US20120122874 Combination of a sedative and a neurotransmitter modulator, and methods for treating depression
05/17/2012US20120122873 Amino derivatives of dihydro-1,3,5-triazine used in the treatment of ischemia and/or reperfusion related diseases
05/17/2012US20120122872 Treatment or Prevention of Fungal Infections with PDK1 Inhibitors
05/17/2012US20120122871 Oligomer-Containing Substituted Aromatic Triazine Compounds
05/17/2012US20120122870 Treatment Of Ischemia-Reperfusion Injury
05/17/2012US20120122869 Trizaole compounds that modulate hsp90 activity
05/17/2012US20120122868 Apaf-1 inhibitor compounds
05/17/2012US20120122867 Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
05/17/2012US20120122866 Topical pharmaceutical composition including rel-n-[6-[(2r,6s)-2,6-dimethyl-4-morpholinyl]-3-pyridinyl]-2-methyl-4'-(trifluoromethoxy)-[1,1'-biphenyl]-3-carboxamide
05/17/2012US20120122865 Isoindoline compounds and methods of their use
05/17/2012US20120122864 Inhibitors of hcv ns5a
05/17/2012US20120122863 Quinazolinedione Chymase Inhibitors
05/17/2012US20120122862 Arginine derivatives with np-i antagonistic activity
05/17/2012US20120122861 Bicyclic amide derivatives for enhancing glutamatergic synaptic responses
05/17/2012US20120122860 Solid forms of sulfonamides and amino acids
05/17/2012US20120122859 Methods of using diaminopyrimidine as p2x3 and p2x2/3 receptor modulators for treatment of respiratory and gastrointestinal diseases
05/17/2012US20120122858 Lactam compounds and their use as pharmaceuticals
05/17/2012US20120122857 Heterobicyclic carboxamides as inhibitors for kinases
05/17/2012US20120122855 Benzoxazines, benzothiazines, and related compounds having nos inhibitory activity
05/17/2012US20120122854 Carbocyclic Fused Cyclic Amines
05/17/2012US20120122853 Annelated n-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
05/17/2012US20120122852 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use
05/17/2012US20120122851 Pharmaceutical preparation and delivery system
05/17/2012US20120122850 Biphenyl compounds useful as muscarinic receptor antagonists
05/17/2012US20120122849 Pkm2 modulators for use in the treatment of cancer
05/17/2012US20120122848 (+)-3-hydroxymorphinan derivatives as neuroprotectants
05/17/2012US20120122847 Aurora kinase modulators and method of use
05/17/2012US20120122846 FURO[3,2-d]PYRIMIDINE COMPOUNDS
05/17/2012US20120122845 Method for the production of bioadhesive compact matrices
05/17/2012US20120122844 Method of treating contrast-induced nephropathy
05/17/2012US20120122843 Compounds and Their Use for Treatment of Amyloid Beta-Related Diseases
05/17/2012US20120122842 Nampt and rock inhibitors
05/17/2012US20120122841 Biological Markers Predictive Of Anti-Cancer Response To Insulin-like Growth Factor-1 Receptor Kinase Inhibitors
05/17/2012US20120122840 Compounds and therapeutic uses thereof
05/17/2012US20120122839 Novel pyrrolidin-2-ones
05/17/2012US20120122838 Heterocyclic compounds and uses thereof
05/17/2012US20120122837 Inhibitors of fatty acid binding protein
05/17/2012US20120122836 Polymorphic form of 1-(4--2-ethyl-benzyl)-azetidine-3-carboxylic
05/17/2012US20120122835 Poly (ADP-Ribose) Polymerase (PARP) Inhibitors
05/17/2012US20120122834 Small molecule cd4 mimetics and uses thereof
05/17/2012US20120122833 Deuterium-enriched meropenem
05/17/2012US20120122832 Method of making cefquinome particles
05/17/2012US20120122831 Method and device for rapid detection of bacterial antibiotic resistance/susceptibility
05/17/2012US20120122830 Pregnenolone sulfate for the treatment of neurologic disorders
05/17/2012US20120122829 Pharmaceutical composition for transdermal or transmucous administration
05/17/2012US20120122828 Method for on-demand contraception
05/17/2012US20120122827 Novel derivatives of cholest-4-en-3-one oxime, pharmaceutical compositions containing them and preparation method
05/17/2012US20120122826 Novel quinuclidine derivatives and medicinal compositions containing the same
05/17/2012US20120122825 Use of picoplatin to treat prostate cancer
05/17/2012US20120122824 Reduction of Side Effects From Aromatase Inhibitors Used for Treating Breast Cancer
05/17/2012US20120122823 Aqueous drug delivery system
05/17/2012US20120122822 Compositions for reducing beta-amyloid-induced neurotoxicity comprising beta-secretase inhibitor
05/17/2012US20120122821 Steroid-containing sustained release intraocular implants and related methods
05/17/2012US20120122820 Prodrugs and the use thereof
05/17/2012US20120122819 Guanine riboswitch binding compounds and their use as antibiotics
05/17/2012US20120122818 Lung-targeted drugs
05/17/2012US20120122817 Heterocyclic urea derivatives and methods of use thereof
05/17/2012US20120122816 Compositions and methods for organ preservation
05/17/2012US20120122815 Composition for Treating Dry Eye and Related Methods of Manufacture and Methods of Use
05/17/2012US20120122814 Composition for Prevention or Treatment of Hypertrophic Scars or Keloids
05/17/2012US20120122813 Composition containing oligosaccharides for the treatment/prevention of infections
05/17/2012US20120122812 Anti-aging agent
05/17/2012US20120122811 Bicyclic nucleosides and nucleotides as therapeutic agents
05/17/2012US20120122810 Fused Pentacyclic Polyethers
05/17/2012US20120122809 Antibacterial aminoglycoside analogs
05/17/2012US20120122808 Macrolide synthesis process and solid-state forms
05/17/2012US20120122807 Cardiac Glycoside Analogs in Combination with Emodin for Cancer Therapy
05/17/2012US20120122806 Method of lowering glycemic index of foods
05/17/2012US20120122805 Pesticidal compositions
05/17/2012US20120122804 Substituted quinobenzoxazine analogs
05/17/2012US20120122801 Mannose-6-phosphate receptor mediated gene transfer into muscle cells
05/17/2012US20120122795 Accelerated extension of axons
05/17/2012US20120122793 S-Protected Cysteine Analogs and Related Compounds
05/17/2012US20120122792 S-t-BUTYL PROTECTED CYSTEINE DI-PEPTIDE ANALOGS AND RELATED COMPOUNDS
05/17/2012US20120122787 Methods for treating polycystic kidney disease (pkd) or other cyst forming diseases
05/17/2012US20120122785 Combination of a leucine source and an omega- 3 unsaturated fatty acid source for use in the treatment of hypercalcaemia
05/17/2012US20120122784 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
05/17/2012US20120122780 Compounds, Compositions and Methods for Modulating Uric Acid Levels
05/17/2012US20120122777 Diagnostic agent for ischemic heart disease risk group
05/17/2012US20120122776 Dpp-iv inhibitors for treatment of diabetes in pediatric patients
05/17/2012US20120122773 N-substituted-cyclic amino derivative
1 ... 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 ... 7860